IRIS
STEFANI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.355
EU - Europa 12.564
AS - Asia 11.260
SA - Sud America 2.076
AF - Africa 1.227
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 2
Totale 48.526
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.495
SG - Singapore 5.913
RU - Federazione Russa 3.458
IT - Italia 3.135
CN - Cina 3.003
IE - Irlanda 1.810
BR - Brasile 1.785
UA - Ucraina 1.597
VN - Vietnam 853
CA - Canada 676
CI - Costa d'Avorio 631
FR - Francia 605
DE - Germania 579
KR - Corea 307
GB - Regno Unito 299
SE - Svezia 247
NG - Nigeria 242
IN - India 241
FI - Finlandia 194
BD - Bangladesh 120
AR - Argentina 116
MX - Messico 109
SN - Senegal 101
IQ - Iraq 98
ES - Italia 97
PL - Polonia 94
NL - Olanda 86
HK - Hong Kong 85
TR - Turchia 84
ZA - Sudafrica 83
JP - Giappone 81
BE - Belgio 73
ID - Indonesia 69
PK - Pakistan 63
CH - Svizzera 57
UZ - Uzbekistan 56
AT - Austria 53
EC - Ecuador 41
VE - Venezuela 35
GR - Grecia 34
BJ - Benin 31
MA - Marocco 30
AE - Emirati Arabi Uniti 29
JO - Giordania 28
KE - Kenya 27
IR - Iran 26
LB - Libano 26
CO - Colombia 24
DZ - Algeria 22
UY - Uruguay 22
IL - Israele 21
KZ - Kazakistan 21
SA - Arabia Saudita 21
AU - Australia 20
EG - Egitto 18
JM - Giamaica 17
LT - Lituania 17
MY - Malesia 17
NO - Norvegia 17
PY - Paraguay 17
RO - Romania 17
NP - Nepal 16
TN - Tunisia 16
CL - Cile 14
PH - Filippine 14
CZ - Repubblica Ceca 12
EU - Europa 12
BO - Bolivia 11
NI - Nicaragua 11
PE - Perù 11
BG - Bulgaria 10
CR - Costa Rica 10
OM - Oman 9
HN - Honduras 8
HR - Croazia 8
PA - Panama 8
SY - Repubblica araba siriana 8
AZ - Azerbaigian 7
BY - Bielorussia 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
HU - Ungheria 7
KG - Kirghizistan 7
AO - Angola 6
BH - Bahrain 6
DK - Danimarca 6
MD - Moldavia 6
PT - Portogallo 6
RS - Serbia 6
AL - Albania 5
MT - Malta 5
TT - Trinidad e Tobago 5
AM - Armenia 4
NZ - Nuova Zelanda 4
XK - ???statistics.table.value.countryCode.XK??? 4
BN - Brunei Darussalam 3
CG - Congo 3
CY - Cipro 3
EE - Estonia 3
LK - Sri Lanka 3
Totale 48.471
Salva come PNG Salva come JPEG
Città #
Dallas 3.435
Singapore 3.395
Santa Clara 2.484
Dublin 1.806
Chandler 1.653
Jacksonville 1.630
San Jose 1.433
Moscow 1.364
Ashburn 1.097
Boardman 769
Catania 752
Abidjan 631
Chicago 625
Nanjing 488
Lawrence 486
Cambridge 484
Los Angeles 474
Andover 473
Lauterbourg 472
Hefei 454
Toronto 441
Houston 421
Beijing 407
Seoul 307
Des Moines 283
Ho Chi Minh City 282
San Mateo 249
Munich 233
Civitanova Marche 194
Council Bluffs 189
New York 187
São Paulo 187
Hanoi 186
Wilmington 175
Messina 159
Nanchang 155
Hebei 148
Bremen 140
Shenyang 137
Buffalo 134
Lagos 124
Palermo 123
Saint Petersburg 118
Jiaxing 113
Helsinki 106
Ottawa 105
Dakar 101
Changsha 97
Rome 96
Abuja 95
Belpasso 89
Montreal 85
Tianjin 83
Grafing 82
Orem 79
Tokyo 78
Hong Kong 74
The Dalles 74
Milan 73
Brussels 72
Seattle 67
Warsaw 67
Lappeenranta 65
Columbus 64
Rio de Janeiro 58
Brooklyn 55
Johannesburg 54
Phoenix 54
Chennai 53
London 53
Denver 49
Haiphong 46
Stockholm 46
Amsterdam 43
Atlanta 41
Boston 41
Mexico City 40
Baghdad 39
Brolo 38
Dong Ket 38
Syracuse 38
Acireale 37
Poplar 37
San Francisco 36
Brasília 34
Da Nang 34
Belo Horizonte 32
Curitiba 32
Hangzhou 32
Cotonou 31
Reggio Calabria 31
Falls Church 30
Washington 30
Frankfurt am Main 29
Tashkent 29
Kunming 28
Ankara 27
Amman 26
Manchester 26
Bari 25
Totale 32.521
Salva come PNG Salva come JPEG
Nome #
Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA) 379
A Snapshot of the COL-R Acinetobacter baumannii Comparative Transcriptome by RNA-seq. 313
Balancing the Virulence and Antimicrobial Resistance in VISA DAP-R CA-MRSA Superbug 311
Guida alla determinazione delle alghe del Mediterraneo. Parte I: Alghe azzurre (Cyanophyta o Cyanobacteria) 298
Gut Microbiota and Cancer: From Pathogenesis to Therapy 254
Attività antibatterica di netilmicina e netilmicina/desametasone, in paragone con altri antibiotici, verso Gram-positivi e Gram-negativi isolati da infezioni oculari. 188
Bactericidal activity of Ceftobiprole combined with different antibiotics against selected gram-positive isolates 181
Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens 181
A novel delta-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-inermediate S.aureus 177
Potential associations among alteration of salivary mirnas, saliva microbiome structure, and cognitive impairments in autistic children 177
A Clinical protocol for safety and colonization in human rhinopharynx by S.salivarius 24SMBc 176
Single-nucleotide polymorphism and downstream signaling associated with chronic rhinosinusitis, asthma, allergy and acetylsalicylic-acid intolerance: a narrative review 175
A multicenter study on central venous catheter-associated infections in Italy 175
Ability of osteoblast invasion of rifampicin- methicillin-resistant Staphylococcus aureus isolates 169
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 168
Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy 164
Ceftazidime-Avibactam Treatment for Klebsiella pneumoniae Bacteremia in Preterm Infants in NICU: A Clinical Experience 163
Interactions of Gram-Positive Bacterial Membrane Vesicles and Hosts: Updates and Future Directions 161
Colistin Resistant A. baumannii: Genomic and Transcriptomic Traits Acquired Under Colistin Therapy 160
Heteroaryl-Ethylenes as New Effective Agents for High Priority Gram-Positive and Gram-Negative Bacterial Clinical Isolates 158
Bactericidal and synergistic activity of ceftobiprole combined with different antibiotics against selected Gram-positive isolates 157
Different modulatory effects of four methicillin‐resistant Staphylococcus aureus clones on MG-63 osteoblast-like cells 157
Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011 155
A new reliable screening method for the evaluation of VISA and hVISA strains by “Vancomycin-Teicoplanin MIC Test Strip” (VTMTS) (Liofilchem srl, Italy). 154
A bioinformatic approach to microbial proteome analysis 153
A clinical study comparing ofloxacin (0,3%) with tobramycin (0,3%), for th tretment of external ocular infection 152
Burkholderia cepacia complex in cystic fibrosis and non cystic fibrosis patients: identification of a cluster of epidemic lineages 152
"USO DI STREPTOCOCCUS SALIVARIUS NEL TRATTAMENTO DELLE INFEZIONI CRONICHE DEL TRATTO RESPIRATORIO" 152
Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability 150
Burden of Rifampicin- and Methicillin-Resistant Staphylococcus aureus in Italy. 149
ACTION OF CLINDAMYCIN-PHOSPHATE IN FOREIGN-BODY INFECTIONS DUE TO STAPHYLOCOCCUS-EPIDERMIDIS IN MICE 148
Active surveillance of invasive pneumococcal diseases in Sicilian children (2009-2011) Working group: Abate C, Allù M, Arena M, Armenia FR, Barberi I, Barraco G, Belbruno F, Bozzanca L, Bruno G, Canzeroni G, Casà C, Casuccio N, Contrino L, Cuccia M, Cavaleri G, D'Angelo R, Di Naro S, Di Stefano P, Dones P, Emma F, Falsaperla R, Ferrera G, Geraci G, Ghiraldi E, Gramaglia G, Iacono F, Incorpora, Lizzio A, Madonia S, Malato C, Marcantonio G, Margani S, Merlino F, Nicastro L, Palillo L, Pavone P, Porto A, Puglisi G, Rotondo A, Salvo V, Santagati M.C., Santangelo C, Sferrazza I, Stassi G, Tumminelli F, Varvaro A, Vitale M. 148
Streptococcus salivarius 24SMBc Genome Analysis Reveals New Biosynthetic Gene Clusters Involved in Antimicrobial Effects on Streptococcus pneumoniae and Streptococcus pyogenes 148
Agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus 147
A new reliable screening method for the evaluation of VISA and hVISA strains by “Vancomycin-Teicoplanin MIC Test Strip” (VTMTS) 146
Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations 144
Aspetti Microbiologici e legislativi delle piscine:valutazione dell’azione batterica di due disinfettanti a base di cloro, comunemente utilizzati in piscina 144
Microbiome differences in periodontal, peri-implant, and healthy sites: a cross-sectional pilot study 143
Attività antibatterica in vitro dell’associazione thrimethoprim/sulfadiazina 141
Discriminatory Weight of SNPs in Spike SARS-CoV-2 Variants: A Technically Rapid, Unambiguous, and Bioinformatically Validated Laboratory Approach 141
Analysis of polycystic kidney disease with two new microsatellite markers 140
Activity of Tigecycline against well characterized multi-resistant Gram-positive strains 139
VISA CA-MRSA Transcriptomic Adaptations Emerging Under Teicoplanin Therapy 138
Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion 138
Testing surgical face masks in an emergency context: The experience of italian laboratories during the COVID-19 pandemic crisis 138
Cefditoren versus community acquired respiratory pathogens: time kill studies 137
CovidTGI: A tool to investigate the temporal genetic instability of SARS-CoV-2 variants 136
Antibiotico-resistenza, Genomovar Status e Distribuzione di markers di patogenicità in Burkholderia cepacia complex 136
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study 136
A contribute on the fosfomycin mechanism of resistance in MDR organisms 135
Attività in vitro di tigeciclina e altri antibiotici verso Acinetobacter baumannii isolati da infezioni gravi in Italia 135
Combination of aztreonam, ceftazidime–avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis 135
Application of bacteriotherapy in human rhinopharynx 135
AF141943 - Haemophilus parainfluenzae 16S/23S long rRNA spacer region; tRNA-Ile and tRNA-Ala genes, complete sequences 134
44 Oral streptococci producing bacteriocin-like inhibitory substances (BLIS) as oral probiotics against potential upper respiratory tract pathogens 134
Genomic characterization of a new biofilm-forming and adhesive st398 human-adapted mssa lineage causing septic knee arthritis following surgical reconstruction 134
The Rapid Phenotypic Susceptibility Testing in Real-Life Experience: How the MIC Values Impact on Sepsis Fast Diagnostic Workflow 133
Berberine-styrene-co-maleic acid nanomicelles: unlocking opportunities for the treatment and prevention of bacterial infections 132
Detection of methicillin-resistant Staphylococcus aureus persistence in osteoblasts using imaging flow cytometry 132
Evaluation of the Effects of Heteroaryl Ethylene Molecules in Combination with Antibiotics: A Preliminary Study on Control Strains 131
Omic insights into various ceftazidime-avibactam-resistant Klebsiella pneumoniae isolates from two southern Italian regions 131
Prediction of antimicrobial resistance of Klebsiella pneumoniae from genomic data through machine learning 131
Oregano and Thyme Essential Oils Encapsulated in Chitosan Nanoparticles as Effective Antimicrobial Agents against Foodborne Pathogens 131
PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer 130
Antipneumococcal activity of telithromycin in comparison with other drugs in relation to the presence of different resistance genes 130
Activity of telithromycin against multi-drug resistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance determinants 130
Eventi avversi e trigger C12: Stroke in ospedale 130
AGR DEFICIENCY AND EXPRESSION CHANGES IN REGULATORY AND CELL WALL GENES RESPONSIBLE FOR HVISA AND VISA PHENOTYPES 129
Colonization and persistence of S.salivarius 24 SMBc in human rhinopharynx 129
Antibacterial activity of PZ-601 against well-characterized and recent clinical isolates of methicillin-resistant Staphylococcus aureus 129
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method. 129
Staphylococcus aureus ST228 and ST239 as models for expression studies of diverse markers during osteoblast infection and persistence 129
Added value of multi-pathogen probe-based real-time PCR SeptiFast in the rapid diagnosis of bloodstream infections in patients with bacteraemia. 128
agr-genotyping of biofilm producing Staphylococcus aureus 128
"USO DI STREPTOCOCCUS SALIVARIUS NEL TRATTAMENTO DI MALATTIE DEL TRATTO RESPIRATORIO" 128
Heteroaryl-ethylenes as new effective agents in the fight against high priority Gram-positive and Gram-negative bacterial clinical isolates 127
Antibacterial activity of netilmicin and netilmicin/desametasone fixed combination against the most common ocular isolates 127
Cell-free supernatant of Lactobacillus gasseri 1A-TV shows a promising activity to eradicate carbapenem-resistant Klebsiella pneumoniae colonization 127
Deciphering DAP and Glycopeptide mechanism of action-related transcriptome profiling by RNA-seq in S.aureus. 126
Gain-in omic signatures of colistin-resistant Acinetobacter baumannii undergoing colistin therapy. 126
CHEESE MAKING USING WOODENEQUIPMENT PROMOTE BIOFILM FORMATION BY S AUREUS 126
Change in daptomycin killing activity in MRSA clones under vancomycin challenge 126
BURKHOLDERIA GLADIOLI, A BIOCONTROL AGENT AGAINST GREEN AND BLU MOLD OF FRUITS 126
CRISPR-Cas system molecular organization and functionality in clinical MDR Staphylococcus epidermidis. 125
Heteroresistance to glycopeptides in Italian methicillin-resistant Staphylococcus aureus (MRSA) isolates 125
Antibacterial activity of Netilmicin and Netilmicin/Dexamethasone fixed combination against the most common ocular isolates 125
A multicenter performance evaluation of cefiderocol MIC results: ComASP in comparison to CLSI broth microdilution 124
AGR FUNCTIONALITY AND ABILITY TO FORM BIOFILM IN COL AND NRS149 STAPHYLOCOCCUS AUREUS 123
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology and genomovar status 123
COLRAcinetobacter baumannii sRNA Signatures: Computational Comparative Identification and Biological Targets 123
Infections with VIM-1 metallo beta-lactamase producing Enterobacter cloacae and their correlation with clinical outcome 122
Modulating Activity of Vancomycin and Daptomycin on the Expression of Autolysis Cell-Wall Turnover and Membrane Charge Genes in hVISA and VISA Strains 122
Detection of the IncX3 plasmid carrying blaKPC-3in a Serratia marcescens strain isolated from a kidney-liver transplanted patient 122
Extensively drug-resistant ArmA-producing Acinetobacter baumannii in an Italian intensive care unit 122
In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cef ixime, in comparison with other drugs, against Haemophilus influenzae, haemophilus parainfluenzae, moraxella catarrhalis and streptococcus pneumoniae 122
Attività in vitro di piperacillina/tazobactam in paragone ad altri antibiotici nei confronti di germi multiresistenti 121
Colistin resistance onset strategies and genomic mosaicism in clinical acinetobacter baumannii lineages 121
Characterization of Panton-Valentine leukocidine positive methicillin-resistant Staphylococcus aureus in Italy 119
Biofilm production and correlation with agr-allele distribution in medical-devices associated with Staphylococcus aureus 119
Burkholderia cepacia complex: evoluzione delle prospettive nel controllo dell’infezione 119
Totale 14.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021544 0 0 0 0 0 0 0 0 0 28 363 153
2021/20223.612 428 497 31 60 538 39 504 108 374 50 95 888
2022/20235.690 539 186 111 533 550 1.016 37 885 1.423 50 264 96
2023/20242.627 147 384 111 184 113 500 58 133 34 91 486 386
2024/202510.075 150 1.393 634 463 2.246 996 449 420 849 1.005 643 827
2025/202620.406 1.338 1.092 3.891 1.417 3.369 3.889 2.754 549 946 1.161 0 0
Totale 49.345